BIOFIRE SPOTFIRE PCR Laboratory Analyzer – Placement Agreement
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
ADMINISTRATION SERVICES BRANCH
Contract Value
Not provided
Codes & Classification
Solicitation Number
75H711-Q-0026
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
Classification Code
6635
Additional Details
Documents3
The Indian Health Service (IHS), under the Department of Health and Human Services, has issued a Combined Synopsis/Solicitation for a placement agreement to provide Biofire Spotfire FDA-approved PCR (Polymerase Chain Reaction) CLIA Waived analyzers to laboratory departments at hospital and service unit locations within the Oklahoma Area. This procurement, identified by 75H711-Q-0026, aims to enhance testing capabilities and improve patient care for eligible Native American patients registered for ambulatory services at these outpatient federal facilities.
The scope of this agreement encompasses the uninterrupted provision of Biofire Spotfire analyzer services throughout the contract term. The analyzers must be FDA-approved and CLIA Waived, ensuring compliance with regulatory standards and suitability for clinical laboratory environments. The primary objective is to support the Oklahoma Area IHS facilities in delivering timely and accurate diagnostic testing, thereby advancing the quality of healthcare provided to the Native American community.
Key requirements include the supply, installation, and maintenance of Biofire Spotfire PCR analyzers, with a focus on seamless integration into existing laboratory workflows. The expected deliverables are fully operational analyzers that meet all federal and clinical standards, along with ongoing support to guarantee continuous service.
The procurement is classified under NAICS Code 334516 (Analytical Laboratory Instrument Manufacturing) and Product Service Code 6635, indicating a focus on laboratory instrumentation. The place of performance is Oklahoma City, Oklahoma, with all services to be rendered within the United States.
The contracting entity is the Administration Services Branch of the Indian Health Service, a federal office responsible for managing this solicitation. The primary point of contact for this opportunity is Krishna Harriman, who can be reached at [email protected] for further inquiries.
This solicitation is currently active, with offers due by August 4, 2026, at 11:00 AM CST. Notably, Amendment 01 has been issued, rescinding the original attachments and highlighting changes to the solicitation. Interested contractors should review the amended documents carefully to ensure compliance with updated requirements.
The procurement is designated as BICiv set-aside, though further details regarding eligibility or special considerations are not provided in the notice. Contractors specializing in analytical laboratory instrument manufacturing and capable of delivering FDA-approved, CLIA Waived PCR analyzers are encouraged to evaluate this opportunity for alignment with their capabilities.
For additional information and access to the solicitation documents, contractors may visit the official SAM.gov opportunity page at https://sam.gov/opp/d6cdc63856e143f6bc1cd4a77a85d967/view.
This placement agreement represents a critical initiative to bolster laboratory diagnostics within the Oklahoma Area IHS, supporting the ongoing mission to provide high-quality healthcare to Native American communities.